2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Cryptococcosis: new trials by email Literature Review of Cryptococcosis trials Research Report on Cryptococcosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Amphotericin B for Non-HIV Cryptococcal Meningitis Patients Amphotericin B 0.5 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks., Amphotericin B 0.7 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks. - Cryptococcal Meningitis, Antifungal Agents | Phase 4 | Unknown | Huashan Hospital | 250 | 2023-08-13 | 2023-12-21 |
| Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis Liposomal amphotericin B - Cryptococcal Meningitis | Phase 4 | Unknown | Hui Bu | 40 | 2016-01-01 | 2016-02-22 |
Bacterial Infections and Mycoses (2) · Central Nervous System Diseases (2) · Central Nervous System Fungal Infections (2) · Central Nervous System Infections (2) · Infections (2) · Meningitis (2) · Meningitis, Fungal (2) · Mycoses (2) · Nervous System Diseases (2) · Neuroinflammatory Diseases (2)
Amphotericin B (1) · liposomal amphotericin B (1)
Huashan Hospital (1) · Hui Bu (1)
China (1)
Hui Bu, MD (1)